ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Novel Drug Delivery Systems for Cancer Therapy Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-31J13345
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Novel Drug Delivery Systems for Cancer Therapy Market Research Report 2023
BUY CHAPTERS

Global Novel Drug Delivery Systems for Cancer Therapy Market Research Report 2025

Code: QYRE-Auto-31J13345
Report
June 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Advanced Medical Isotope Corporation
BIND Therapeutics
Boston Scientific Corporation
BTG Plc
CeloNova BioSciences Inc.
Cook Medical Inc
Cospheric
Covidien
Eckert & Ziegler BEBIG
EmboMedics, Inc.
Kobo Products; Inc.
Merit Medical Systems Inc
Mo-Sci Corporation
Nanobiotix
Polysciences
Sirtex Medical, Inc.
Terumo Corporation

Novel Drug Delivery Systems for Cancer Therapy Market Size

The global market for Novel Drug Delivery Systems for Cancer Therapy was valued at US$ 6753 million in the year 2024 and is projected to reach a revised size of US$ 7586 million by 2031, growing at a CAGR of 1.7% during the forecast period.

Novel Drug Delivery Systems for Cancer Therapy Market

Novel Drug Delivery Systems for Cancer Therapy Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems for Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems for Cancer Therapy.
The Novel Drug Delivery Systems for Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Novel Drug Delivery Systems for Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Drug Delivery Systems for Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Novel Drug Delivery Systems for Cancer Therapy Market Report

Report Metric Details
Report Name Novel Drug Delivery Systems for Cancer Therapy Market
Accounted market size in year US$ 6753 million
Forecasted market size in 2031 US$ 7586 million
CAGR 1.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Novel Drug Delivery Systems for Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Novel Drug Delivery Systems for Cancer Therapy Market growing?

Ans: The Novel Drug Delivery Systems for Cancer Therapy Market witnessing a CAGR of 1.7% during the forecast period 2025-2031.

What is the Novel Drug Delivery Systems for Cancer Therapy Market size in 2031?

Ans: The Novel Drug Delivery Systems for Cancer Therapy Market size in 2031 will be US$ 7586 million.

Who are the main players in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The main players in the Novel Drug Delivery Systems for Cancer Therapy Market are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation

What are the Application segmentation covered in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The Applications covered in the Novel Drug Delivery Systems for Cancer Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The Types covered in the Novel Drug Delivery Systems for Cancer Therapy Market report are Embolization Particles – Drug Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal Radiation Therapy, Holmium-Based Microspheres, Liquid Embolics – Onyx, Other

Recommended Reports

Cancer Drug Delivery

Cancer Immunotherapy

Radiation & Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Embolization Particles – Drug Eluting Beads
1.2.3 Polyvinyl Alcohol Particles
1.2.4 Microspheres
1.2.5 Gelatin-Based Embolization Devices
1.2.6 Selective Internal Radiation Therapy
1.2.7 Holmium-Based Microspheres
1.2.8 Liquid Embolics – Onyx
1.2.9 Other
1.3 Market by Application
1.3.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Perspective (2020-2031)
2.2 Global Novel Drug Delivery Systems for Cancer Therapy Growth Trends by Region
2.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Novel Drug Delivery Systems for Cancer Therapy Market Dynamics
2.3.1 Novel Drug Delivery Systems for Cancer Therapy Industry Trends
2.3.2 Novel Drug Delivery Systems for Cancer Therapy Market Drivers
2.3.3 Novel Drug Delivery Systems for Cancer Therapy Market Challenges
2.3.4 Novel Drug Delivery Systems for Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue
3.1.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Novel Drug Delivery Systems for Cancer Therapy Revenue
3.4 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio
3.4.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2024
3.5 Global Key Players of Novel Drug Delivery Systems for Cancer Therapy Head office and Area Served
3.6 Global Key Players of Novel Drug Delivery Systems for Cancer Therapy, Product and Application
3.7 Global Key Players of Novel Drug Delivery Systems for Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Type
4.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Application
5.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Novel Drug Delivery Systems for Cancer Therapy Market Size (2020-2031)
6.2 North America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size (2020-2031)
7.2 Europe Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size (2020-2031)
9.2 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Medical Isotope Corporation
11.1.1 Advanced Medical Isotope Corporation Company Details
11.1.2 Advanced Medical Isotope Corporation Business Overview
11.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.1.4 Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.1.5 Advanced Medical Isotope Corporation Recent Development
11.2 Bind Therapeutics
11.2.1 Bind Therapeutics Company Details
11.2.2 Bind Therapeutics Business Overview
11.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Introduction
11.2.4 Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.2.5 Bind Therapeutics Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Details
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.3.4 Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.3.5 Boston Scientific Corporation Recent Development
11.4 BTG plc
11.4.1 BTG plc Company Details
11.4.2 BTG plc Business Overview
11.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Introduction
11.4.4 BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.4.5 BTG plc Recent Development
11.5 CeloNova BioSciences, Inc.
11.5.1 CeloNova BioSciences, Inc. Company Details
11.5.2 CeloNova BioSciences, Inc. Business Overview
11.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.5.4 CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.5.5 CeloNova BioSciences, Inc. Recent Development
11.6 Cook Medical, Inc.
11.6.1 Cook Medical, Inc. Company Details
11.6.2 Cook Medical, Inc. Business Overview
11.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.6.4 Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.6.5 Cook Medical, Inc. Recent Development
11.7 Cospheric LLC
11.7.1 Cospheric LLC Company Details
11.7.2 Cospheric LLC Business Overview
11.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Introduction
11.7.4 Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.7.5 Cospheric LLC Recent Development
11.8 Covidien, plc
11.8.1 Covidien, plc Company Details
11.8.2 Covidien, plc Business Overview
11.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Introduction
11.8.4 Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.8.5 Covidien, plc Recent Development
11.9 Eckert & Ziegler BEBIG
11.9.1 Eckert & Ziegler BEBIG Company Details
11.9.2 Eckert & Ziegler BEBIG Business Overview
11.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Introduction
11.9.4 Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.9.5 Eckert & Ziegler BEBIG Recent Development
11.10 EmboMedics, Inc.
11.10.1 EmboMedics, Inc. Company Details
11.10.2 EmboMedics, Inc. Business Overview
11.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.10.4 EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.10.5 EmboMedics, Inc. Recent Development
11.11 Kobo Products, Inc.
11.11.1 Kobo Products, Inc. Company Details
11.11.2 Kobo Products, Inc. Business Overview
11.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.11.4 Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.11.5 Kobo Products, Inc. Recent Development
11.12 Merit Medical Systems, Inc.
11.12.1 Merit Medical Systems, Inc. Company Details
11.12.2 Merit Medical Systems, Inc. Business Overview
11.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.12.4 Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.12.5 Merit Medical Systems, Inc. Recent Development
11.13 Mo-Sci Corporation
11.13.1 Mo-Sci Corporation Company Details
11.13.2 Mo-Sci Corporation Business Overview
11.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.13.4 Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.13.5 Mo-Sci Corporation Recent Development
11.14 Nanobiotix
11.14.1 Nanobiotix Company Details
11.14.2 Nanobiotix Business Overview
11.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Introduction
11.14.4 Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.14.5 Nanobiotix Recent Development
11.15 Polysciences, Inc.
11.15.1 Polysciences, Inc. Company Details
11.15.2 Polysciences, Inc. Business Overview
11.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.15.4 Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.15.5 Polysciences, Inc. Recent Development
11.16 Sirtex Medical, Inc.
11.16.1 Sirtex Medical, Inc. Company Details
11.16.2 Sirtex Medical, Inc. Business Overview
11.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.16.4 Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.16.5 Sirtex Medical, Inc. Recent Development
11.17 Terumo Corporation
11.17.1 Terumo Corporation Company Details
11.17.2 Terumo Corporation Business Overview
11.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.17.4 Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
11.17.5 Terumo Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Advanced Medical Isotope Corporation
BIND Therapeutics
Boston Scientific Corporation
BTG Plc
CeloNova BioSciences Inc.
Cook Medical Inc
Cospheric
Covidien
Eckert & Ziegler BEBIG
EmboMedics, Inc.
Kobo Products; Inc.
Merit Medical Systems Inc
Mo-Sci Corporation
Nanobiotix
Polysciences
Sirtex Medical, Inc.
Terumo Corporation
List of Tables
 Table 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Embolization Particles – Drug Eluting Beads
 Table 3. Key Players of Polyvinyl Alcohol Particles
 Table 4. Key Players of Microspheres
 Table 5. Key Players of Gelatin-Based Embolization Devices
 Table 6. Key Players of Selective Internal Radiation Therapy
 Table 7. Key Players of Holmium-Based Microspheres
 Table 8. Key Players of Liquid Embolics – Onyx
 Table 9. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2020-2025)
 Table 13. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2026-2031)
 Table 15. Novel Drug Delivery Systems for Cancer Therapy Market Trends
 Table 16. Novel Drug Delivery Systems for Cancer Therapy Market Drivers
 Table 17. Novel Drug Delivery Systems for Cancer Therapy Market Challenges
 Table 18. Novel Drug Delivery Systems for Cancer Therapy Market Restraints
 Table 19. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players (2020-2025)
 Table 21. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2024)
 Table 22. Ranking of Global Top Novel Drug Delivery Systems for Cancer Therapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Novel Drug Delivery Systems for Cancer Therapy, Headquarters and Area Served
 Table 25. Global Key Players of Novel Drug Delivery Systems for Cancer Therapy, Product and Application
 Table 26. Global Key Players of Novel Drug Delivery Systems for Cancer Therapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Advanced Medical Isotope Corporation Company Details
 Table 52. Advanced Medical Isotope Corporation Business Overview
 Table 53. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product
 Table 54. Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 55. Advanced Medical Isotope Corporation Recent Development
 Table 56. Bind Therapeutics Company Details
 Table 57. Bind Therapeutics Business Overview
 Table 58. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product
 Table 59. Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 60. Bind Therapeutics Recent Development
 Table 61. Boston Scientific Corporation Company Details
 Table 62. Boston Scientific Corporation Business Overview
 Table 63. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product
 Table 64. Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 65. Boston Scientific Corporation Recent Development
 Table 66. BTG plc Company Details
 Table 67. BTG plc Business Overview
 Table 68. BTG plc Novel Drug Delivery Systems for Cancer Therapy Product
 Table 69. BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 70. BTG plc Recent Development
 Table 71. CeloNova BioSciences, Inc. Company Details
 Table 72. CeloNova BioSciences, Inc. Business Overview
 Table 73. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 74. CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 75. CeloNova BioSciences, Inc. Recent Development
 Table 76. Cook Medical, Inc. Company Details
 Table 77. Cook Medical, Inc. Business Overview
 Table 78. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 79. Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 80. Cook Medical, Inc. Recent Development
 Table 81. Cospheric LLC Company Details
 Table 82. Cospheric LLC Business Overview
 Table 83. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product
 Table 84. Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 85. Cospheric LLC Recent Development
 Table 86. Covidien, plc Company Details
 Table 87. Covidien, plc Business Overview
 Table 88. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product
 Table 89. Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 90. Covidien, plc Recent Development
 Table 91. Eckert & Ziegler BEBIG Company Details
 Table 92. Eckert & Ziegler BEBIG Business Overview
 Table 93. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product
 Table 94. Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 95. Eckert & Ziegler BEBIG Recent Development
 Table 96. EmboMedics, Inc. Company Details
 Table 97. EmboMedics, Inc. Business Overview
 Table 98. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 99. EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 100. EmboMedics, Inc. Recent Development
 Table 101. Kobo Products, Inc. Company Details
 Table 102. Kobo Products, Inc. Business Overview
 Table 103. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 104. Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 105. Kobo Products, Inc. Recent Development
 Table 106. Merit Medical Systems, Inc. Company Details
 Table 107. Merit Medical Systems, Inc. Business Overview
 Table 108. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 109. Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 110. Merit Medical Systems, Inc. Recent Development
 Table 111. Mo-Sci Corporation Company Details
 Table 112. Mo-Sci Corporation Business Overview
 Table 113. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product
 Table 114. Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 115. Mo-Sci Corporation Recent Development
 Table 116. Nanobiotix Company Details
 Table 117. Nanobiotix Business Overview
 Table 118. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product
 Table 119. Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 120. Nanobiotix Recent Development
 Table 121. Polysciences, Inc. Company Details
 Table 122. Polysciences, Inc. Business Overview
 Table 123. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 124. Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 125. Polysciences, Inc. Recent Development
 Table 126. Sirtex Medical, Inc. Company Details
 Table 127. Sirtex Medical, Inc. Business Overview
 Table 128. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
 Table 129. Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 130. Sirtex Medical, Inc. Recent Development
 Table 131. Terumo Corporation Company Details
 Table 132. Terumo Corporation Business Overview
 Table 133. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product
 Table 134. Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 135. Terumo Corporation Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Novel Drug Delivery Systems for Cancer Therapy Picture
 Figure 2. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Embolization Particles – Drug Eluting Beads Features
 Figure 5. Polyvinyl Alcohol Particles Features
 Figure 6. Microspheres Features
 Figure 7. Gelatin-Based Embolization Devices Features
 Figure 8. Selective Internal Radiation Therapy Features
 Figure 9. Holmium-Based Microspheres Features
 Figure 10. Liquid Embolics – Onyx Features
 Figure 11. Other Features
 Figure 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Application: 2024 VS 2031
 Figure 14. Hospitals Case Studies
 Figure 15. Clinics Case Studies
 Figure 16. Others Case Studies
 Figure 17. Novel Drug Delivery Systems for Cancer Therapy Report Years Considered
 Figure 18. Global Novel Drug Delivery Systems for Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Novel Drug Delivery Systems for Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region: 2024 VS 2031
 Figure 21. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players in 2024
 Figure 22. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2024
 Figure 24. North America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2020-2031)
 Figure 26. United States Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2020-2031)
 Figure 30. Germany Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2020-2031)
 Figure 38. China Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2020-2031)
 Figure 46. Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2020-2031)
 Figure 50. Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Advanced Medical Isotope Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 54. Bind Therapeutics Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 55. Boston Scientific Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 56. BTG plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 57. CeloNova BioSciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 58. Cook Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 59. Cospheric LLC Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 60. Covidien, plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 61. Eckert & Ziegler BEBIG Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 62. EmboMedics, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 63. Kobo Products, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 64. Merit Medical Systems, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 65. Mo-Sci Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 66. Nanobiotix Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 67. Polysciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 68. Sirtex Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 69. Terumo Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiation Therapy Treatment Planning System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment Planning Software Market Research Report 2025
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Proton Therapy Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions